Tag: Furiex Pharmaceuticals

  • Gainers on Major news: Apple Inc. (NASDAQ:AAPL), AstraZeneca plc (NYSE:AZN), Furiex Pharmaceuticals (NASDAQ:FURX), Google Inc. (NASDAQ:GOOG), Charter Communications (NASDAQ:CHTR)

    Apple Inc. (NASDAQ:AAPL) is proving too big to ignore in the bond market, where investors nursing losses from the computer maker’s $17 billion debt sale last year are still seen lining up to participate in a new offering that may come as soon as this week and be of similar size. Apple Inc. (NASDAQ:AAPL) shares after opening at $572.80 moved to $595.75 on last trade day and at the end of the day closed at $594.09. Company price to sales ratio in past twelve months was calculated as 2.91 and price to cash ratio as 12.38. Apple Inc. (NASDAQ:AAPL) showed a positive weekly performance of 11.85%.

    Pfizer (NYSE:PFE) is still chasing AstraZeneca (NYSE:AZN). Pfizer previously made an offer for the rival, British drug maker in January and was promptly rejected. But it seems Pfizer isn’t quite so easily swayed the company reportedly contacted AstraZeneca on April 26, in light of recent market events, to reopen the discussion regarding a possible merger. Again, AstraZeneca declined to engage in discussions. AstraZeneca plc (ADR) (NYSE:AZN) shares advanced 12.16% in last trading session and ended the day on $77.01. AZN return on equity ratio is recorded as 19.10% and its return on assets is 8.10%. AstraZeneca plc (ADR) (NYSE:AZN) yearly performance is 56.40%.

    Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Furiex Pharmaceuticals, Inc. (NASDAQ:FURX) by Forest Laboratories, Inc. (NYSE: FRX). On April 28, 2014, Furiex and Forest Labs announced the signing of a definitive merger agreement pursuant to which Furiex shareholders will receive $95 in cash for each share of Furiex common stock and up to $30 per share in a Contingent Value Right that may be payable based on the pending approval of the eluxadoline drug. Furiex Pharmaceuticals Inc. (NASDAQ:FURX) shares moved up 28.57% in last trading session and was closed at $103.05, while trading in range of $102.41 – $104.56. Furiex Pharmaceuticals Inc. (NASDAQ:FURX) year to date (YTD) performance is 145.30%.

    Google Inc. (NASDAQ:GOOG) said it has begun testing its self-driving cars on city streets, a crucial new phase in its quest to eventually make the technology a standard feature in automobiles. Google Inc. (NASDAQ:GOOG) weekly performance is -2.17%. On last trading day company shares ended up $517.15. Google Inc. (NASDAQ:GOOG) distance from 50-day simple moving average (SMA50) is -5.11%.

    Charter Communications, Inc. (NASDAQ:CHTR)-Comcast make $7.3 billion deal. As part of the deal, the company will sell 1.4 million subscribers to Charter Communications Inc. for $7.3 billion in cash and spin off another 2.5 million subscribers into a company in which Charter will take a one-third stake. Charter Communications, Inc. (NASDAQ:CHTR) shares after opening at $132.34 moved to $142.70 on last trade day and at the end of the day closed at $140.05. Company price to sales ratio in past twelve months was calculated as 1.86 and price to cash ratio as 720.59. Charter Communications, Inc. (NASDAQ:CHTR) showed a positive weekly performance of 13.30%.